Russell Investments Group
OYST

Russell Investments Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Russell Investments Group’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,657
Closed -$125K – 3228
2020
Q4 		$125K Sell
6,657
-17,700
-73% -$382K ﹤0.01% 2838
2020
Q3 		$514K Hold
24,357
– – ﹤0.01% 2382
2020
Q2 		$703K Buy
+24,357
New +$734K ﹤0.01% 2234

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Russell Investments Group's OYST Position: Q1 2021 in Review

Russell Investments Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2021, closing a stake of 6,657 shares — an estimated $125K sold.

Russell Investments Group first reported a position in OYST in Q2 2020 and held it in 3 quarters. The position peaked at $703K in Q2 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q1 2021.

  • Russell Investments Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 6,657 Oyster Point Pharma, Inc. Common Stock shares in Q1 2021, an estimated $125K.
  • Russell Investments Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Russell Investments Group's Oyster Point Pharma, Inc. Common Stock position peaked at $703K in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.